Approaches to Utilizing Bone-targeting Therapies in mBC
Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
What to Know About PARP Inhibitors for Advanced Ovarian Cancer
What to Know About PARP Inhibitors for Advanced Ovarian Cancer
How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer
How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 02, 2023
06:30 PM - 07:30 PM PDT
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 09, 2023
12:00 PM - 01:00 PM EDT
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC